A clinical study to study the drug Appalakara chooranam on Vatham

A Prospective open labelled phase II non randomized clinical trial on mineral drug of Appalakara Chooranam for the treatment of Cegana vatham (Cervical Spondylosis)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/03/012681

Enrollment

Registered

2018-03-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cegana Vatham

Interventions

Intervention1: Applakara Chooranam: 30mg/kg/BW/daily twice times per day with water Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Neck pain radiating to upper limb with or without numbness giddiness and neck stiffness Restriction neck movement Willing for doing laboratory investigations and x ray imaging The neck disability index score should be equal or greater then 40 present

Exclusion criteria

Exclusion criteria: Traumatic injury Systemic hypertension Ischemic heart diseases Chronic kidney disease Tuberculosis in spine Secondary malignancy Chronic systemic illness Congenital spinal anomalies

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug Appalakara chooranam on Cegana VathamTimepoint: The therapeutic efficacy of trial drug Appalakara chooranam on Cegana Vatham	—

Secondary

Measure	Time frame
Evaluation of Siddha diagnostic parametersTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr A Manoharan MD Siddha

Government Siddha Medical college and hospital

drmanoharan25@gmail.com9443886700

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026